The price of Nuvectis Pharma Inc (NASDAQ: NVCT) closed at $8.20 in the last session, down -1.68% from day before closing price of $8.34. In other words, the price has decreased by -$0.14 from its previous closing price. On the day, 59577 shares were traded.
Ratios:
We take a closer look at NVCT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.75 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on July 13, 2022, initiated with a Buy rating and assigned the stock a target price of $21.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 18 ’24 when BENTSUR RON bought 5,000 shares for $10.29 per share. The transaction valued at 51,450 led to the insider holds 3,242,484 shares of the business.
BENTSUR RON bought 640 shares of NVCT for $7,091 on Oct 10 ’23. The Chairman & CEO now owns 3,237,484 shares after completing the transaction at $11.08 per share. On Oct 09 ’23, another insider, BENTSUR RON, who serves as the Chairman & CEO of the company, bought 830 shares for $11.19 each. As a result, the insider paid 9,288 and bolstered with 3,236,844 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVCT now has a Market Capitalization of 148.19M and an Enterprise Value of 129.07M.
Stock Price History:
Over the past 52 weeks, NVCT has reached a high of $18.65, while it has fallen to a 52-week low of $6.20. The 50-Day Moving Average of the stock is 8.41, while the 200-Day Moving Average is calculated to be 11.14.
Shares Statistics:
According to the various share statistics, NVCT traded on average about 107.00K shares per day over the past 3-months and 150.15k shares per day over the past 10 days. A total of 17.42M shares are outstanding, with a floating share count of 6.67M. Insiders hold about 62.46% of the company’s shares, while institutions hold 8.52% stake in the company. Shares short for NVCT as of Mar 15, 2024 were 766.09k with a Short Ratio of 7.16, compared to 602.19k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.31% and a Short% of Float of 8.32%.
Earnings Estimates
The company has 2 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.4 for the current quarter, with a high estimate of -$0.4 and a low estimate of -$0.4, while EPS last year was -$0.27. The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.36 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.49 and -$1.59 for the fiscal current year, implying an average EPS of -$1.54. EPS for the following year is -$1.63, with 2 analysts recommending between -$1.51 and -$1.76.
